Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Ambroxol

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Ambroxol?

Ambroxol is an investigational drug.

There have been 21 clinical trials for Ambroxol. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2005.

The most common disease conditions in clinical trials are Pharyngitis, Parkinson Disease, and Gaucher Disease. The leading clinical trial sponsors are Boehringer Ingelheim, Sanofi, and Hyundai Pharmaceutical Co., LTD.

Recent Clinical Trials for Ambroxol
A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol Hydrochloride 30 mg Twice Daily and Placebo as Expectorant Therapies in Adult Chinese Patients With RespiratorZambon SpAPhase 3
Ambroxol Therapy for Patients With Type 1 Gaucher Disease and Suboptimal Response to Enzyme Replacement TherapyShaare Zedek Medical CenterPhase 2
Efficacy and Safety Study of New Ambroxol Hardboiled Lozenges in Acute PharyngitisSanofiPhase 3

See all Ambroxol clinical trials

Clinical Trial Summary for Ambroxol

Top disease conditions for Ambroxol
Top clinical trial sponsors for Ambroxol

See all Ambroxol clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.